MAPT and Alzheimer disease: Increased Aβ levels in AD trigger tau pathology; this leads to microtubule deficits and related disorders, such as defective microtubule assembly and axonal transport deficits, which are likely to affect the neurotrophic signaling of NTFs, followed by neuronal death, and eventually, disease [88,89].